Waterman Michael

Chief Sales Officer Michael Waterman buys 214,600 shares of ACVA at $4.66 after -37.4% 30-day decline

Michael Waterman, Chief Sales Officer, purchased 214,600 shares valued at $1,000,036.00 on 2026-02-26 at $4.66, increasing his holdings by +60.5% from 354,502 to 569,102 shares. This is a substantial open-market buy during sharp drawdown conditions: the stock is -71.3% from its 52-week high of $17.04 and down -37.4% in the 30-day window preceding the purchase. At the same-ticker level, Waterman's track record shows mixed outcomes: his 2 of 3 prior sells at ACVA were well-timed (90d returns were -21.5% and +4.9%, with the May 2025 sale of -21.5% showing the best foresight), but aggregate 30-day outcomes after his prior sells at ACVA averaged negative. The company remains unprofitable (net income of -$24,465,000.00 in the latest quarter) despite annual revenue growth of +19.2%, which establishes a fundamental context of operational losses against which to evaluate the purchase.

Chief Sales Officer Michael Waterman sells 223,330 shares of ACVA at $17.00; stock down 26.9% from 52-week high and unprofitable

Waterman, the Chief Sales Officer, sold 223,330 shares (35.5% of his pre-transaction holdings) for $3,796,610.00 on 2025-05-13 at $17.00 per share, leaving him with 405,636 shares. The sale occurs when ACVA trades at $16.93, down 26.9% from its 52-week high of $23.17, and the company reported a net loss of $14.8M on $182.7M revenue in its latest quarter despite strong 32.4% annual revenue growth. His prior two sales at ACVA were poorly timed by the 90-day standard: the September 2024 sale saw stock rise +4.9% within 90 days, and the March 2025 sale shows -7.8% over 30 days with 90-day outcome not yet measurable. Cross-ticker, his timing record shows a 0.00% well-timed rate on 2 prior sells with an average 90-day return of +4.9%, indicating consistent poor timing of market exits. This sale represents a material reduction in his ACVA exposure at a depressed valuation relative to 52-week levels, though his demonstrated inability to time exits and the company's ongoing unprofitability suggest investors should monitor whether subsequent price action validates this decision.

Chief Sales Officer Waterman sold 115,987 shares at $16.10; stock now $14.60, down 37.0% from 52-week high.

Michael Waterman, Chief Sales Officer of ACV Auctions, sold 115,987 shares on 2025-03-25 at $16.10 per share, reducing his holdings by 26.1% from 443,551 to 327,564 shares. The sale occurred at a price $1.50 above today's level ($14.60), yet the company's stock has deteriorated significantly: -37.0% from its 52-week high and -33.0% over the past 90 days alone. His cross-ticker track record shows a 0.00% well-timed sell rate across all prior transactions, and at ACVA specifically, his single prior sale on 2024-09-17 produced a +4.9% 90-day return—meaning he sold before a subsequent gain, not a decline. The company itself remains unprofitable (full-year net income was negative), though it is growing revenue at +32.4% annually. The timing of this sale relative to the stock's sharp recent decline and the insider's historical pattern of selling into strength rather than weakness warrants investor scrutiny of whether this represents a material shift in confidence or is simply a routine reduction.

CSO Michael Waterman sold 75,000 ACVA shares at $20.24; stock now at 52-week high of $20.67 after 9.2% 30-day rally.

Michael Waterman, Chief Sales Officer, sold 75,000 shares (75.0K shares) worth $1,518,000.00 on 2024-09-17 at $20.24, reducing his holdings from 441,310 shares to 366,310 shares. This sale occurred as ACVA's stock reached its 52-week high of $20.67, following a 9.2% rally over the prior 30 days and 16.5% over 90 days. The company remains unprofitable with negative net income of $-17,063,000.00 despite quarterly revenue of $160,624,000.00 and annual revenue growth of 14.2%. The timing of this substantial reduction in the CSO's stake at price peaks warrants investor attention given the company's ongoing earnings challenges.